BindingDB logo
myBDB logout

BDBM103788 US8551978, I-58::US8816088, I-58::US9394275, I-58::US9572802, Compound I-58::US9682957, I-58

SMILES: C[C@@H](Cc1ccc(CCNC(=O)c2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12

InChI Key: InChIKey=BODWRNBUQHEVTC-OJDGJXOUNA-N

Data: 6 KI  2 EC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 103788   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103788
PNG
(US8551978, I-58 | US8816088, I-58 | US9394275, I-5...)
Show SMILES C[C@@H](Cc1ccc(CCNC(=O)c2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
Show InChI InChI=1/C51H56N6O7/c1-34(53-33-46(59)42-20-22-45(58)49-43(42)21-23-47(60)55-49)32-36-14-12-35(13-15-36)24-28-52-50(62)38-16-18-39(19-17-38)56(2)48(61)27-31-57-29-25-40(26-30-57)64-51(63)54-44-11-7-6-10-41(44)37-8-4-3-5-9-37/h3-23,34,40,46,53,58-59H,24-33H2,1-2H3,(H,52,62)(H,54,63)(H,55,60)/t34-,46-/s2
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

Article
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent


Assay Description
compounds were performed with [3H]NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a con...


US Patent US9572802 (2017)


Article DOI: 10.1021/jm020455u
BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103788
PNG
(US8551978, I-58 | US8816088, I-58 | US9394275, I-5...)
Show SMILES C[C@@H](Cc1ccc(CCNC(=O)c2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
Show InChI InChI=1/C51H56N6O7/c1-34(53-33-46(59)42-20-22-45(58)49-43(42)21-23-47(60)55-49)32-36-14-12-35(13-15-36)24-28-52-50(62)38-16-18-39(19-17-38)56(2)48(61)27-31-57-29-25-40(26-30-57)64-51(63)54-44-11-7-6-10-41(44)37-8-4-3-5-9-37/h3-23,34,40,46,53,58-59H,24-33H2,1-2H3,(H,52,62)(H,54,63)(H,55,60)/t34-,46-/s2
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.200n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell me...


US Patent US8816088 (2014)


BindingDB Entry DOI: 10.7270/Q2TQ6068
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103788
PNG
(US8551978, I-58 | US8816088, I-58 | US9394275, I-5...)
Show SMILES C[C@@H](Cc1ccc(CCNC(=O)c2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
Show InChI InChI=1/C51H56N6O7/c1-34(53-33-46(59)42-20-22-45(58)49-43(42)21-23-47(60)55-49)32-36-14-12-35(13-15-36)24-28-52-50(62)38-16-18-39(19-17-38)56(2)48(61)27-31-57-29-25-40(26-30-57)64-51(63)54-44-11-7-6-10-41(44)37-8-4-3-5-9-37/h3-23,34,40,46,53,58-59H,24-33H2,1-2H3,(H,52,62)(H,54,63)(H,55,60)/t34-,46-/s2
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.200 -13.8n/an/an/an/an/an/a37



Theravance Respiratory Company LLC

US Patent


Assay Description
Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentr...


US Patent US9394275 (2016)


BindingDB Entry DOI: 10.7270/Q2NS0SS8
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103788
PNG
(US8551978, I-58 | US8816088, I-58 | US9394275, I-5...)
Show SMILES C[C@@H](Cc1ccc(CCNC(=O)c2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
Show InChI InChI=1/C51H56N6O7/c1-34(53-33-46(59)42-20-22-45(58)49-43(42)21-23-47(60)55-49)32-36-14-12-35(13-15-36)24-28-52-50(62)38-16-18-39(19-17-38)56(2)48(61)27-31-57-29-25-40(26-30-57)64-51(63)54-44-11-7-6-10-41(44)37-8-4-3-5-9-37/h3-23,34,40,46,53,58-59H,24-33H2,1-2H3,(H,52,62)(H,54,63)(H,55,60)/t34-,46-/s2
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

Article
US Patent
0.200n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent


Assay Description
compounds were performed with [3H]NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a con...


US Patent US9572802 (2017)


Article DOI: 10.1021/jm020455u
BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103788
PNG
(US8551978, I-58 | US8816088, I-58 | US9394275, I-5...)
Show SMILES C[C@@H](Cc1ccc(CCNC(=O)c2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
Show InChI InChI=1/C51H56N6O7/c1-34(53-33-46(59)42-20-22-45(58)49-43(42)21-23-47(60)55-49)32-36-14-12-35(13-15-36)24-28-52-50(62)38-16-18-39(19-17-38)56(2)48(61)27-31-57-29-25-40(26-30-57)64-51(63)54-44-11-7-6-10-41(44)37-8-4-3-5-9-37/h3-23,34,40,46,53,58-59H,24-33H2,1-2H3,(H,52,62)(H,54,63)(H,55,60)/t34-,46-/s2
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.200n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103788
PNG
(US8551978, I-58 | US8816088, I-58 | US9394275, I-5...)
Show SMILES C[C@@H](Cc1ccc(CCNC(=O)c2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
Show InChI InChI=1/C51H56N6O7/c1-34(53-33-46(59)42-20-22-45(58)49-43(42)21-23-47(60)55-49)32-36-14-12-35(13-15-36)24-28-52-50(62)38-16-18-39(19-17-38)56(2)48(61)27-31-57-29-25-40(26-30-57)64-51(63)54-44-11-7-6-10-41(44)37-8-4-3-5-9-37/h3-23,34,40,46,53,58-59H,24-33H2,1-2H3,(H,52,62)(H,54,63)(H,55,60)/t34-,46-/s2
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
0.200n/an/an/an/an/an/an/an/a



Theravance, Inc.

US Patent


Assay Description
Radioligand binding assay using muscarinic receptors.


US Patent US8551978 (2013)


BindingDB Entry DOI: 10.7270/Q2Q81BPC
More data for this
Ligand-Target Pair
Adrenergic receptor


(Homo sapiens (Human))
BDBM103788
PNG
(US8551978, I-58 | US8816088, I-58 | US9394275, I-5...)
Show SMILES C[C@@H](Cc1ccc(CCNC(=O)c2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
Show InChI InChI=1/C51H56N6O7/c1-34(53-33-46(59)42-20-22-45(58)49-43(42)21-23-47(60)55-49)32-36-14-12-35(13-15-36)24-28-52-50(62)38-16-18-39(19-17-38)56(2)48(61)27-31-57-29-25-40(26-30-57)64-51(63)54-44-11-7-6-10-41(44)37-8-4-3-5-9-37/h3-23,34,40,46,53,58-59H,24-33H2,1-2H3,(H,52,62)(H,54,63)(H,55,60)/t34-,46-/s2
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
n/an/an/an/a 1n/an/an/a25



Theravance Respiratory Company LLC

US Patent


Assay Description
cAMP assays were performed in a radioimmunoassay format using the Flashplate Adenylyl Cyclase Activation Assay System with [125I]-cAMP (NEN SMP004, P...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Adrenergic receptor


(Homo sapiens (Human))
BDBM103788
PNG
(US8551978, I-58 | US8816088, I-58 | US9394275, I-5...)
Show SMILES C[C@@H](Cc1ccc(CCNC(=O)c2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
Show InChI InChI=1/C51H56N6O7/c1-34(53-33-46(59)42-20-22-45(58)49-43(42)21-23-47(60)55-49)32-36-14-12-35(13-15-36)24-28-52-50(62)38-16-18-39(19-17-38)56(2)48(61)27-31-57-29-25-40(26-30-57)64-51(63)54-44-11-7-6-10-41(44)37-8-4-3-5-9-37/h3-23,34,40,46,53,58-59H,24-33H2,1-2H3,(H,52,62)(H,54,63)(H,55,60)/t34-,46-/s2
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem

Similars

US Patent
n/an/an/an/a 1n/an/an/a37



Theravance Respiratory Company LLC

US Patent


Assay Description
cAMP assays were performed in a radioimmunoassay format using the Flashplate Adenylyl Cyclase Activation Assay System with [125I]-cAMP (NEN SMP004, P...


US Patent US9394275 (2016)


BindingDB Entry DOI: 10.7270/Q2NS0SS8
More data for this
Ligand-Target Pair